• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

Is rituximab maintenance therapy useful following rituximab salvage in refractory or relapsed follicular lymphoma? Commentary

D Ritchie

Nature Clinical Practice Oncology | NATURE PUBLISHING GROUP | Published : 2007

DOI: 10.1038/ncponc0842

University of Melbourne Researchers

David Ritchie's Profile Picture
David Ritchie Author

Keywords

Rare Diseases
Life Sciences & Biomedicine
3201 Cardiovascular Medicine and Haematology
6.2 Cellular and Gene Therapies
Lymphatic Research
Cancer
Improves
Fludarabine
Combination
Immunotherapy
Hematology
Cyclophosphamide
Lymphoma
Fcm
32 Biomedical and Clinical Sciences
Mantle Cell Lymphomas
Mantle-Cell Lymphoma
Rituximab
Science & Technology
Follicular Lymphoma
3211 Oncology and Carcinogenesis
Oncology
Maintenance

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224